Stroke outcome measures: a tale of two trialsPeter A Rasmussen
9 August 2013
Sacroplasty: beyond the beginningJoshua A Hirsch, John D Barr, Gregg H Zoarski
9 August 2013
The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation?Kyle M Fargen, Donald Frei, David Fiorella, Cameron G McDougall, Philip M Myers, Joshua A Hirsch, J Mocco
11 June 2013
The tribulations of stroke trialsFelipe C Albuquerque, David Fiorella, Joshua A Hirsch, Charles Prestigiacomo, Robert W Tarr
8 April 2013
Nothing changes on New Year's dayRobert W Tarr
12 December 2012
Interventional Management of Stroke III Trial: establishing the foundationOsama O Zaidat, Marc A Lazzaro, Rishi Gupta, Dileep R Yavagal, Peter A Rasmussen, Joshua A Hirsch, Alicia C Castonguay, Robert W Tarr
7 June 2012
Do less harmFelipe C Albuquerque
5 April 2012
Lessons learnedRobert W Tarr
7 February 2012
The HDE: what is it good for? Absolutely nothing?Charles Joseph Prestigiacomo
7 February 2012
The marrow of lifeRobert W Tarr
13 December 2011